Search hospitals > New Jersey > Paterson
Saint Joseph's Regional Medical Center
Claim this profilePaterson, New Jersey 07503
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoma
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Lymphoid Leukemia
210 reported clinical trials
2 medical researchers
Summary
Saint Joseph's Regional Medical Center is a medical facility located in Paterson, New Jersey. This center is recognized for care of Leukemia, Tumors, Lymphoma, Lymphoblastic Leukemia-Lymphoma, Lymphoid Leukemia and other specialties. Saint Joseph's Regional Medical Center is involved with conducting 210 clinical trials across 352 conditions. There are 2 research doctors associated with this hospital, such as Alissa Kahn and Mehandar Kumar.Area of expertise
1Leukemia
Global LeaderStage II
t(8;21)(q22;q22) positive
t(16;16)(p13;q22) positive
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Alissa KahnSaint Joseph's Regional Medical Center4 years of reported clinical research
Expert in Tumors
Studies Leukemia
40 reported clinical trials
85 drugs studied
Mehandar KumarSaint Joseph's Regional Medical Center3 years of reported clinical research
Studies Cancer
Studies Bladder Cancer
2 reported clinical trials
4 drugs studied
Clinical Trials running at Saint Joseph's Regional Medical Center
Breast Cancer
Acute Lymphoblastic Leukemia
Ovarian Tumors
Germ Cell Tumors
Lymphoma
Ovarian Carcinoma
Testicular Carcinoma
Embryonal Carcinoma
Ovarian Choriocarcinoma
Tumors
FDG-PET/CT Scan Prediction
for Breast Cancer
This trial tests an imaging procedure in patients with a specific type of breast cancer. The test uses a small amount of radioactive sugar to highlight active cancer areas, helping doctors decide if more or less treatment is needed before surgery. This imaging procedure has been used successfully for diagnosis, initial staging, restaging, early treatment response assessment, evaluation of disease spread, and predicting outcomes in breast cancer.
Recruiting1 award Phase 217 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Joseph's Regional Medical Center?
Saint Joseph's Regional Medical Center is a medical facility located in Paterson, New Jersey. This center is recognized for care of Leukemia, Tumors, Lymphoma, Lymphoblastic Leukemia-Lymphoma, Lymphoid Leukemia and other specialties. Saint Joseph's Regional Medical Center is involved with conducting 210 clinical trials across 352 conditions. There are 2 research doctors associated with this hospital, such as Alissa Kahn and Mehandar Kumar.